title: [Neoplastic mastocytosis evolving from a poor prognosis acute myeloid leukemia].
authors.affiliation: Servicio de Hematología y Oncología Médica, Hospital Morales Meseguer, Murcia, España.
authors.forename: Tzu-Hua
authors.initials: TH
authors.lastname: Chen-Liang
authors.affiliation: Servicio de Hematología y Oncología Médica, Hospital Morales Meseguer, Murcia, España.
authors.forename: Andrés
authors.initials: A
authors.lastname: Jerez
authors.affiliation: Laboratori de Citologia Hematològica, Servicio Patología, IMIM (Hospital del Mar Research Institute), Barcelona, España.
authors.forename: Lourdes
authors.initials: L
authors.lastname: Florensa
authors.affiliation: Servicio de Hematología y Oncología Médica, Hospital Morales Meseguer, Murcia, España. Electronic address: fortunog@sehh.es.
authors.forename: Francisco José
authors.initials: FJ
authors.lastname: Ortuño
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage; D018450:Disease Progression; D019008:Drug Resistance, Neoplasm; D017809:Fatal Outcome; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D016130:Immunophenotyping; D007946:Leukemia, Mast-Cell / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics / Q000473:pathology*; D008407:Mast Cells / Q000473:pathology; D009154:Mutation; D009363:Neoplasm Proteins / Q000032:analysis; D014411:Neoplastic Stem Cells / Q000473:pathology; D011379:Prognosis; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives
chemical_list: D009363:Neoplasm Proteins; D003561:Cytarabine; D016179:Granulocyte Colony-Stimulating Factor; D014740:Vidarabine; D015255:Idarubicin